English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduFor people with relapsing-remitting multiple sclerosis (MS), a new study has found that the drug ofatumumab is more effective than teriflunomide at helping people across racial and ethnic groups reach a period of no disease activity. The study is published in the July 17, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Tag: Multiple Schlerosis
Hackensack Meridian Neuroscience Institute Leading The Way In Comprehensive Multiple Sclerosis Research
Explanation of clinical research for MS Awareness month
Fixing rogue brain cells may hold key to preventing neurodegeneration
A team led by scientists at the Case Western Reserve University School of Medicine has identified a new therapeutic approach for combating neurodegenerative diseases.
Harnessing good fats to relieve MS symptoms
Researchers find that fish oil derivative reduces and delays disease–causing inflammation in mouse model of multiple sclerosis
New drug that could aid earlier MS diagnoses approved by FDA for first human clinical trials
A new drug that could make it easier for doctors to diagnose multiple sclerosis (MS) in its earlier stages has been approved for its first human trials by the U.S. Food and Drug Administration (FDA).
Scientists Find Molecular Key to Body Making Healthy T Cells
In a finding that could help lead to new therapies for immune diseases like multiple sclerosis and IBD, scientists report in the Journal of Experimental Medicine identifying a gene and family of proteins critical to the formation of mature and fully functioning T cells in the immune system.